Pharmacy Grand Rounds
Hitting the rESETT Button: Updates in Status Epilepticus Treatment

• ACPE Universal Activity Number (UAN): JA0000238-0000-20-028-L01-P
• Session Type: Knowledge-based
• CE Credits: A maximum of 0.75 contact hour (0.075 CEU) for the following: 
  • AAPA Category 1 CME Credits
  • ACPE
  • AMA PRA Category 1 Credits™
  • ANCC

• Session Fee: Free for Mayo Clinic staff

SESSION LOCATIONS

Live Session: (11:00am - 11:45am CST)

Until future notice, learners must watch Pharmacy Grand Rounds live via the web by going to the Video Exchange and selecting “Pharmacy Grand Rounds” in the “Streaming Now” section.

Participants may attend by viewing: Live Webcast
Video Recording - access two weeks after session date

COURSE DESCRIPTION

Benzodiazepines have been established as preferred initial first-line treatment for status epileptics, but are not always efficacious in achieving cessation of seizures. Second-line antiepileptic therapies including fosphenytoin, levetiracetam, valproate, and phenobarbital are utilized for urgent control, but current status epilepticus guidelines do not specify a preferred agent. Recent evidence has provided clarifications regarding preferred urgent control therapies, yet many further questions remain regarding how this evidence can be incorporated into clinical practice.

At the conclusion of this knowledge-based CE session, participants should be able to:

1. Report current guideline recommendations and gaps in evidence for the treatment of status epilepticus
2. Interpret recent evidence regarding conventional antiepileptic utilization in status epilepticus
3. List three considerations in applying new evidence for status epilepticus treatment into clinical practice

Session Announcement

Session Slides

FACULTY INFORMATION

Kellyn K. Engstrom, PharmD, MPH
PGY2 Emergency Medicine Pharmacy Resident
Mayo Clinic Hospital - Rochester, MN

Kellyn received her Doctor of Pharmacy and Master of Public Health degrees from the University of Wisconsin-Madison.  She completed PGY1 Pharmacy Residency and is the current PGY-2 Emergency Medicine pharmacy resident at Mayo Clinic Hospital -Rochester. She has practice interests in emergency medicine, critical care, and pain management. 

DISCLOSURE STATEMENTS

As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program:

The faculty report the following relationships:

• Kellyn K. Engstrom PharmD, MPH
  • Declares no financial relationships pertinent to this session
  • Declares off-label use of devices and medications will not be discussed during this presentation.

Course Director and Planning Committee Members declare no relevant financial relationship(s) pertinent to this session.  Members include:

• Brenda Amaris
• Mary Ellen Cordes, MS, APRN, CNC, NE-BC
• Michael Huckabee, MPAS, PA-C, PhD
• Wayne (Nick) Nicholson, MD, PharmD, BCPS
• Garrett Schramm, PharmD, BCPS
• Lee Skrupky, PharmD, BCPS